SCHEMBL27724772

SCHEMBL27724772

CCOC(=O)c1ccc(-c2ccccc2)c(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.51
▸ SRD5A2 P31213 1/20 0.49
▸ CYP1A2 P05177 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ AKR1C3 P42330 1/20 0.48
▸ AKR1C2 P52895 1/20 0.48
▸ TUBB4A P04350 1/20 0.47
▸ TUBB P07437 1/20 0.47
▸ TUBA3C P0DPH7 1/20 0.47
▸ TUBA1B P68363 1/20 0.47
▸ TUBA4A P68366 1/20 0.47
▸ TUBB4B P68371 1/20 0.47
▸ TUBB3 Q13509 1/20 0.47
▸ TUBB2A Q13885 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3903631 0.85 EGFR (0.57) PDK2SRD5A2AKR1C3AKR1C2S1PR1
SCHEMBL28022353 0.82 FFAR2 (0.47) SRD5A2AKR1C3AKR1C2S1PR1
SCHEMBL28098468 0.82 MAPT (0.54) SRD5A2AKR1C3AKR1C2MAPTS1PR1
SCHEMBL28771192 0.82 RAB9A (0.51) PDK2CYP1A2KDM4EALDH1A1HPGD
SCHEMBL9488109 0.81 CA12 (0.66) CYP1A2KDM4EALDH1A1RAB9ANPC1
SCHEMBL3586442 0.81 RAB9A (0.53) CYP1A2KDM4EALDH1A1RAB9ANPC1
SCHEMBL1993657 0.81 CA12 (0.56) PDK2CYP1A2KDM4EALDH1A1HPGD
SCHEMBL10973660 0.80 CA12 (0.51) PDK2CYP1A2KDM4EALDH1A1HPGD
SCHEMBL29918535 0.80 MAPT (0.64) PDK2CYP1A2KDM4EALDH1A1RAB9A
SCHEMBL374633 0.80 CA12 (0.54) PDK2CYP1A2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101189226-A Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists HOFFMANN LA ROCHE (CH) 2008-05-28 — — CN disclosed
Send feedback